Goldman in talks to offload Apple credit card, savings products to American Express, source says

Goldman in talks to offload Apple credit card, savings products to American Express, source says


How Goldman Sachs failed at consumer banking

Goldman Sachs is in talks to offload its Apple credit card and high-yield savings account products to American Express, a source told CNBC’s Leslie Picker.

Goldman Sachs and Apple declined to comment. CNBC has also reached out to American Express.

The talks come amid a broader retreat by Goldman from its largely failed consumer banking initiatives, for which CEO David Solomon has taken a great deal of heat. Last week, CNBC reported that the Wall Street giant is preparing to take a huge writedown on its 2021 acquisition of fintech lender GreenSky.

The Wall Street Journal first reported the Goldman talks with American Express. The newspaper said there’s no assurance of a deal, nor is an agreement close.

It would mark an abrupt reversal for the two corporate giants. In October, the Journal reported Goldman and Apple renewed their partnership through 2029. And in April, Goldman Chief Financial Officer Denis Coleman touted a deepening of the partnership.

“This week, we announced the launch of a savings account for Apple Card users. We are excited to deepen our partnership with Apple through this additional offering and to introduce another source of deposit funding for the firm,” Coleman said at the time.

The Journal also reported Friday that Goldman is talking about unloading its General Motors card partnership. CNBC has also reached out to GM for comment.

– CNBC’s Steve Kovach and Hugh Son contributed to this report.



Source

Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18
Business

Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18

Disney has named Josh D’Amaro, chairman of Disney Experiences, as its next CEO, succeeding Bob Iger and clinching a closely watched succession race at the Mouse House. Investors, industry insiders and onlookers have long awaited the announcement of who will take over as the next leader of one of the most storied U.S. companies. The […]

Read More
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Business

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. Patients with obesity or who are overweight lost up to 12.3% of their weight compared with placebo at week 28 in […]

Read More
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Business

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on Jan. 20, 2026. Oscar Molina | CNBC Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in December. […]

Read More